DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes the coronavirus disease 2019 (COVID‐19), known to be more common in the elderly, who also show more severe symptoms and are at higher risk of hospitalization and death. Here, we show that the expression of the angiotensin converting enzyme 2 (ACE2), the SARS‐CoV‐2 cell receptor, increases during aging in mouse and human lungs. ACE2 expression increases upon telomere shortening or dysfunction in both cultured mammalian cells and in vivo in mice. This increase is controlled at the transcriptional level, and Ace2 promoter activity is DNA damage response (DDR)‐dependent. Both pharmacological global DDR inhibition of ATM kinase activity and selective telomeric DDR inhibition by the use of antisense oligonucleotides prevent Ace2 upregulation following telomere damage in cultured cells and in mice. We propose that during aging telomere dysfunction due to telomeric shortening or damage triggers DDR activation and this causes the upregulation of ACE2, the SARS‐CoV‐2 cell receptor, thus contributing to make the elderly more susceptible to the infection.

[1]  S. Crooke,et al.  Antisense technology: an overview and prospectus , 2021, Nature Reviews Drug Discovery.

[2]  D. Baralle,et al.  A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection , 2021, Nature Genetics.

[3]  É. B. Rangel,et al.  COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection , 2021, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  R. DePinho,et al.  Telomeres: history, health, and hallmarks of aging , 2021, Cell.

[5]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[6]  A. Vaiserman,et al.  Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives , 2021, Frontiers in Genetics.

[7]  A. Chinnaiyan,et al.  Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 , 2020, Proceedings of the National Academy of Sciences.

[8]  M. O’Reilly,et al.  Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice , 2020, Scientific Reports.

[9]  M. Blasco,et al.  Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging , 2020, The Journal of cell biology.

[10]  Irving L. Weissman,et al.  A single-cell transcriptomic atlas characterizes ageing tissues in the mouse , 2020, Nature.

[11]  Quanlong Jiang,et al.  Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation , 2020, Aging cell.

[12]  M. Harting,et al.  Understanding the age divide in COVID-19: why are children overwhelmingly spared? , 2020, American journal of physiology. Lung cellular and molecular physiology.

[13]  Supinda Bunyavanich,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. , 2020, JAMA.

[14]  Abraham Aviv,et al.  Telomeres and COVID‐19 , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  V. Jhanji,et al.  Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea , 2020, Eye.

[16]  Martin Stahl,et al.  Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.

[17]  Roland Eils,et al.  SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells , 2020, The EMBO journal.

[18]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[19]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[20]  Fabian J Theis,et al.  SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.

[21]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[22]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[23]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[24]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[25]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[26]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[27]  W. Zuo,et al.  Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.

[28]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[29]  Lin S. Chen,et al.  Determinants of telomere length across human tissues , 2019, bioRxiv.

[30]  Ba,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults , 2020 .

[31]  O. Dreesen,et al.  Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome , 2019, Nature Communications.

[32]  F. d’Adda di Fagagna,et al.  Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage response factors , 2019, Nature Cell Biology.

[33]  P. Opresko,et al.  The impact of oxidative DNA damage and stress on telomere homeostasis , 2019, Mechanisms of Ageing and Development.

[34]  L. Mullenders Solar UV damage to cellular DNA: from mechanisms to biological effects , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[35]  J. Shay,et al.  Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[36]  G. Danuser,et al.  A method for measuring the distribution of the shortest telomeres in cells and tissues , 2017, Nature Communications.

[37]  G. Shivashankar,et al.  Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks , 2017, Nature Cell Biology.

[38]  A. Rauf,et al.  Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  Wei Wang,et al.  DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression , 2017, Journal of cancer metastasis and treatment.

[40]  B. Yousefi,et al.  The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy. , 2017, DNA repair.

[41]  Piero Carninci,et al.  DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response RNAs , 2017, Nature Communications.

[42]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[43]  P. Pelicci,et al.  P66SHC deletion improves fertility and progeric phenotype of late‐generation TERC‐deficient mice but not their short lifespan , 2016, Aging cell.

[44]  N. Dantuma,et al.  Spatiotemporal regulation of posttranslational modifications in the DNA damage response , 2016, The EMBO journal.

[45]  V. Bordignon,et al.  Endoplasmic Reticulum Stress, Genome Damage, and Cancer , 2015, Front. Oncol..

[46]  C. Litterst,et al.  Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution , 2014, Nucleic acids research.

[47]  J. Lingner,et al.  A quantitative telomeric chromatin isolation protocol identifies different telomeric states , 2013, Nature Communications.

[48]  J. Diedrich,et al.  A two-step mechanism for TRF2-mediated chromosome end protection , 2013, Nature.

[49]  Jian Ye,et al.  Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.

[50]  Piero Carninci,et al.  Site-specific DICER and DROSHA RNA products control the DNA damage response , 2012, Nature.

[51]  F. D. D. Fagagna,et al.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.

[52]  Clara Correia-Melo,et al.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence , 2012, Nature Communications.

[53]  S. Jackson,et al.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. , 2011, Genes & development.

[54]  Graziano Pesole,et al.  Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes , 2009, Nucleic Acids Res..

[55]  Wilhelm Palm,et al.  How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.

[56]  R. Korstanje,et al.  The emerging role of ACE2 in physiology and disease† , 2007, The Journal of pathology.

[57]  Xudong Xie,et al.  Age- and gender-related difference of ACE2 expression in rat lung , 2005, Life Sciences.

[58]  Xie Xudong,et al.  Age- and gender-related difference of ACE2 expression in rat lung , 2005, Life Sciences.

[59]  T. Lange,et al.  DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion , 2005, Nature Cell Biology.

[60]  John M Sedivy,et al.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.

[61]  Matthias S. Müller,et al.  The Emerging Role of , 2004 .

[62]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[63]  J. Shay,et al.  Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang* , 2000, The Journal of Biological Chemistry.

[64]  Sandy Chang,et al.  Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice , 1999, Cell.

[65]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[66]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[67]  L. Hartwell,et al.  The DNA Damage Checkpoint , 1997 .

[68]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.